Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)

被引:0
|
作者
Shicheng Guo
Fengyang Yan
Jibin Xu
Yang Bao
Ji Zhu
Xiaotian Wang
Junjie Wu
Yi Li
Weilin Pu
Yan Liu
Zhengwen Jiang
Yanyun Ma
Xiaofeng Chen
Momiao Xiong
Li Jin
Jiucun Wang
机构
[1] Collaborative Innovation Center for Genetics and Development,State Key Laboratory of Genetic Engineering and Ministry of Education Key Laboratory of Contemporary Anthropology
[2] School of Life Sciences and Institutes of Biomedical Sciences,Department of Cardiothoracic Surgery
[3] Fudan University Jiangwan Campus,Department of Cardiothoracic Surgery
[4] Changzheng Hospital of Shanghai,Department of Pneumology
[5] Yangzhou No.1 People’s Hospital,Center for Genetic & Genomic Analysis
[6] Changhai Hospital of Shanghai,Department of Cardiothoracic Surgery
[7] Changhai Hospital of Shanghai,Human Genetics Center
[8] Genesky Biotechnologies Inc.,undefined
[9] Huashan Hospital,undefined
[10] Fudan University,undefined
[11] The University of Texas School of Public Health,undefined
[12] Fudan-Taizhou Institute of Health Sciences,undefined
来源
Clinical Epigenetics | 2015年 / 7卷
关键词
Non-small cell lung cancer; DNA methylation; Biomarker; Batch effect elimination; Diagnosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)
    Guo, Shicheng
    Yan, Fengyang
    Xu, Jibin
    Bao, Yang
    Zhu, Ji
    Wang, Xiaotian
    Wu, Junjie
    Li, Yi
    Pu, Weilin
    Liu, Yan
    Jiang, Zhengwen
    Ma, Yanyun
    Chen, Xiaofeng
    Xiong, Momiao
    Jin, Li
    Wang, Jiucun
    Clinical Epigenetics, 2015, 7 : 2 - 9
  • [2] Predictive biomarkers in the treatment of non-small cell lung cancer (NSCLC)
    Niho, Seiji
    CANCER SCIENCE, 2018, 109 : 423 - 423
  • [3] Identification and validation of novel prognostic biomarkers and therapeutic targets for non-small cell lung cancer
    Lai, Li-Ting
    Ren, Yuan-Hui
    Huai, Ya-Jun
    Liu, Yu
    Liu, Ying
    Wang, Shan-Shan
    Mei, Jin-Hong
    FRONTIERS IN GENETICS, 2023, 14
  • [4] Novel biomarkers of non-small cell lung cancer (NSCLC) stem cells
    Karimi-Busheri, Feridoun
    Zadorozhny, Victoria
    Shawler, Daniel L.
    Fakhrai, Habib
    CANCER RESEARCH, 2011, 71
  • [5] EVALUATION OF BIOMARKERS IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER (NSCLC)
    FOEMMEL, RS
    ALEXANDER, NA
    HIRSHAUT, Y
    KATOPODIS, N
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 182 - 182
  • [6] Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC)
    Bodor, J. Nicholas
    Boumber, Yanis
    Borghaei, Hossein
    CANCER, 2020, 126 (02) : 260 - 270
  • [7] The Evaluation of Serum Biomarkers for Non-small Cell Lung Cancer (NSCLC) Diagnosis
    Fang, Rui
    Zhu, Yong
    Khadka, Vedbar S.
    Zhang, Fan
    Jiang, Bin
    Deng, Youping
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [8] miRNAs as biomarkers and for the early detection of non-small cell lung cancer (NSCLC)
    Han, Yichao
    Li, Hecheng
    JOURNAL OF THORACIC DISEASE, 2018, 10 (05) : 3119 - 3131
  • [9] Biomarkers for targeted therapy selection in non-small cell lung cancer (NSCLC)
    Paz-Ares, L.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S4 - S4
  • [10] Identification of a DNA methylation signature in liquid biopsy for early non-small cell lung cancer (NSCLC) diagnosis
    Diaz-Lagares, A.
    Mendez-Gonzalez, J.
    Herves, D.
    Saigi, M.
    Pajares, M. J.
    Garcia, D.
    Crujeiras, A. B.
    Lopez-Lopez, R.
    Pio, R.
    Montuenga, L. M.
    Zulueta, J. J.
    Nadal, E.
    Rosell, A.
    Esteller, M.
    Sandoval, J.
    CANCER RESEARCH, 2016, 76